This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

DATATRAK November Industry Events

CLEVELAND, Oct. 31, 2012 /PRNewswire/ --  D ATATRAK International, Inc. (OTCQX: DATA), a leader in developing cloud-based, unified eClinicalâ„¢ technologies and delivering related services for the clinical trials industry, today announced members of its management team will be participating on various industry panels during the month of November. Additionally, D ATATRAK will hold a webinar titled "Image Data Capture in Clinical Trials" with its newest CRO Connect Partnerâ„¢, ABX-CRO.

Association of Clinical Research Professionals Minnesota Chapter Clinical Trial Boot Camp Minneapolis, MN November 3, 2012

D ATATRAK's Vice President of Clinical & Consulting Services, Dr. Bill Gluck, will contribute his expertise to the panel discussion "Stop Sweating the Small Stuff: How to use data management systems to your advantage in the era of risk-based monitoring."

ACRP's mission is to provide global leadership to promote integrity and excellence for the clinical research profession. The boot camp will cover the basics of how a research protocol moves from initiation through FDA audit.

2nd Annual Interactive Response Technologies for Clinical Trials Philadelphia, PA November 8 & 9, 2012

D ATATRAK's Chief Technology Officer, Chris Wilke, will serve as moderator during the session "Best Practices and Industry Approaches for Understanding the IRT Vendor Landscape." D ATATRAK will also be exhibiting at the conference.

The conference focuses on gaining insights into IVR/IWR system utilization in clinical trials and learning how companies use clinical IRTs to increase efficiencies and decrease costs.

D ATATRAK Webinar with CRO Connect Partnerâ„¢, ABX-CRO November 29th at 11 a.m. ESTImage Data Capture in Clinical Trials

ABX-CRO will discuss solutions for controlled exchange of image data in clinical trials, which give CROs and pharmaceutical companies complete web-based control of virtually any trial data, according to today's traceability and safety standards.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 -2.90%
FB $116.73 7.20%
GOOG $691.02 -2.10%
TSLA $247.54 -1.60%
YHOO $36.59 -0.97%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs